Septerna’s $288M IPO is another sign of the market warming to biotech investment

Celebrating his company’s upsized initial public offering (IPO), Septerna CEO Jeffrey Finer rang the opening bell on the Nasdaq stock exchange on Friday morning in New York, in the latest sign of …